Aortyx raises €13.8m to advance bioresorbable vascular patch
Aortyx intends to use the financing to achieve first-in-human readiness for its bioresorbable vascular patch, designed to treat aortic tears, thereby bringing the product closer to market.
DermaSensor’s ESS device achieves 96% sensitivity in skin cancer detection, say studies
Cognito’s Spectris AD trial shows promise in slowing Alzheimer’s progression
SoundHealth’s SONU Band gets FDA approval for paediatric nasal congestion relief
Neurent Medical’s Neuromark system gains FDA clearance for chronic rhinitis
Wandercraft secures $75m in Series D funding for robotic innovations
Analysis
View More
Risks
View MoreNavigating the impact of interstate armed conflict on the medical device development industry
By understanding and preparing for the potential impacts of geopolitical instability, medical device companies can enhance their resilience and continue to deliver critical healthcare solutions in an increasingly complex global...
More Risks
White Papers
View More
Societal polarisation and its impact on the medical device development industry
Addressing the challenges posed by extreme weather events in the medical device development industry
Economic downturn: challenges and opportunities in the medical device development industry
Biodiversity loss and ecosystem collapse: the impact on the medical device development industry